DNA methylation, molecular genetic, and linkage studies in prostate cancer

David F. Jarrard; G. Steven Bova; William B. Isaacs

doi:10.1002/(sici)1097-0045(1996)6+<36::aid-pros8>3.0.co;2-i

DNA methylation, molecular genetic, and linkage studies in prostate cancer

David F. Jarrard, G. Steven Bova, William B. Isaacs

School of Medicine

Research output: Contribution to journal › Article › peer-review

Abstract

Molecular biologic studies have now identified a number of important genetic and epigenetic mechanisms that cause alterations in growth and differentiation genes in prostate cancer. In addition to DNA deletion and point mutation. DNA methylation represents a new paradigm for the inactivation of tumor suppressor or growth suppressor genes. The identification of new genes, including a prostate cancer susceptibility locus, may furnish further insight into the molecular characteristics of prostate cancer and permit the early identification of affected individuals.

Original language	English (US)
Pages (from-to)	36-44
Number of pages	9
Journal	Prostate
Volume	28
Issue number	3 SUPPL. 6
DOIs	https://doi.org/10.1002/(sici)1097-0045(1996)6+<36::aid-pros8>3.0.co;2-i
State	Published - Jan 1 1996

Keywords

DNA methylation
linkage analysis
prostate cancer
tumor suppressor

ASJC Scopus subject areas

Oncology
Urology

Access to Document

10.1002/(sici)1097-0045(1996)6+<36::aid-pros8>3.0.co;2-i

Fingerprint Dive into the research topics of 'DNA methylation, molecular genetic, and linkage studies in prostate cancer'. Together they form a unique fingerprint.

Cite this

@article{f2104c7c3d3c4670a92a1541bdc4d4a7,

title = "DNA methylation, molecular genetic, and linkage studies in prostate cancer",

abstract = "Molecular biologic studies have now identified a number of important genetic and epigenetic mechanisms that cause alterations in growth and differentiation genes in prostate cancer. In addition to DNA deletion and point mutation. DNA methylation represents a new paradigm for the inactivation of tumor suppressor or growth suppressor genes. The identification of new genes, including a prostate cancer susceptibility locus, may furnish further insight into the molecular characteristics of prostate cancer and permit the early identification of affected individuals.",

keywords = "DNA methylation, linkage analysis, prostate cancer, tumor suppressor",

author = "Jarrard, {David F.} and Bova, {G. Steven} and Isaacs, {William B.}",

year = "1996",

month = jan,

day = "1",

doi = "10.1002/(sici)1097-0045(1996)6+<36::aid-pros8>3.0.co;2-i",

language = "English (US)",

volume = "28",

pages = "36--44",

journal = "Prostate",

issn = "0270-4137",

publisher = "Wiley-Liss Inc.",

number = "3 SUPPL. 6",

}

TY - JOUR

T1 - DNA methylation, molecular genetic, and linkage studies in prostate cancer

AU - Jarrard, David F.

AU - Bova, G. Steven

AU - Isaacs, William B.

PY - 1996/1/1

Y1 - 1996/1/1

N2 - Molecular biologic studies have now identified a number of important genetic and epigenetic mechanisms that cause alterations in growth and differentiation genes in prostate cancer. In addition to DNA deletion and point mutation. DNA methylation represents a new paradigm for the inactivation of tumor suppressor or growth suppressor genes. The identification of new genes, including a prostate cancer susceptibility locus, may furnish further insight into the molecular characteristics of prostate cancer and permit the early identification of affected individuals.

AB - Molecular biologic studies have now identified a number of important genetic and epigenetic mechanisms that cause alterations in growth and differentiation genes in prostate cancer. In addition to DNA deletion and point mutation. DNA methylation represents a new paradigm for the inactivation of tumor suppressor or growth suppressor genes. The identification of new genes, including a prostate cancer susceptibility locus, may furnish further insight into the molecular characteristics of prostate cancer and permit the early identification of affected individuals.

KW - DNA methylation

KW - linkage analysis

KW - prostate cancer

KW - tumor suppressor

UR - http://www.scopus.com/inward/record.url?scp=0029878651&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029878651&partnerID=8YFLogxK

U2 - 10.1002/(sici)1097-0045(1996)6+<36::aid-pros8>3.0.co;2-i

DO - 10.1002/(sici)1097-0045(1996)6+<36::aid-pros8>3.0.co;2-i

M3 - Article

C2 - 8630228

AN - SCOPUS:0029690256

VL - 28

SP - 36

EP - 44

JO - Prostate

JF - Prostate

SN - 0270-4137

IS - 3 SUPPL. 6

ER -